Cathie Wood’s ARK sells Alphabet stock, buys Meta and Beam Therapeutics
Cathie Wood’s ARK sells Alphabet stock, buys Meta and Beam Therapeutics Investing.com
Covered in this story
What has happened since
- Meta Platforms is down 0.7% since this was published, 43 days ago.
- Beam Therapeutics Inc is down 2.4% since this was published, 43 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Meta Platforms
- UBS: $738 → $884 by Oct 2027 · Buy via MarketBeat
- Goldman Sachs: $738 → $762 by Oct 2027 · Buy via MarketBeat
- Goldman Sachs: $763 → $860 by Oct 2027 · Buy via TipRanks
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Member calls on Meta Platforms
Members have posted price targets on $META, scored on how close they land.
See the calls →Dalsna Finance is currently tracking 78 stories mentioning Meta Platforms, the earliest published 30 Jun 2026.
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.